Bloomberg Law
Free Newsletter Sign Up
Login
BROWSE
Bloomberg Law
Welcome
Login
Advanced Search Go
Free Newsletter Sign Up

OraSure to Boost Covid Rapid Test Production Under Federal Award

Sept. 22, 2021, 10:15 PM

OraSure Technologies Inc. will increase domestic manufacturing of its InteliSwab Covid-19 rapid test from 8.3 million to 16.7 million tests per month by March 2024 under a new contract with the federal government, according to a source familiar with the award.

The tests are to be made in Bethlehem, Pennsylvania, and will be produced in one more U.S. site. The company will get $109 million under the agreement to make the tests, which are authorized by the Food and Drug Administration.

This deal is part of a $2 billion investment, announced by the Biden administration earlier this month, to make ...